Trials / Sponsors / Guido A. Davidzon, MD, SM
Guido A. Davidzon, MD, SM
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Novel Clinical Target in Fragile X Syndrome Fragile X Syndrome (FXS) | Phase 1 | 2021-01-12 |
| Terminated | [18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Healthy Subject, Intracranial Neoplasm, Glioblastoma | Phase 1 | 2018-04-23 |